Objective: To assess the effects of supplementation with the carotenoids, b-carotene or lycopene, at levels achievable within a diet rich in fruit and vegetables, on immune function in a group of free-living healthy elderly. Design: A double-blind randomized placebo-controlled trial. T cell subsets and the expression of functionally associated cell surface molecules, quanti®ed by¯ow cytometry, and lectin-stimulated lymphocyte proliferation, were compared before and following the treatment period. Subjects: Fifty-eight subjects aged over 65 y were recruited; 52 were included in the ®nal analysis. Interventions: Participants received one placebo, one lycopene (13.3 mg) or one b-carotene (8.2 mg) capsule daily for 12 weeks. Results: No signi®cant differences were observed in any of the parameters examined following either lycopene or b-carotene supplementation. Conclusions: In well-nourished, free-living, healthy elderly individuals, supplementation with relatively low levels of b-carotene or lycopene is not associated with either a bene®cial or detrimental effects on several aspects of cell-mediated immunity. Sponsorship: Financial support was provided by the Commission of the European Communities, speci®c programme AIR2 CT93-0888 DGXII SSMA,`Increased fruit and vegetable consumption within the EC: potential health bene®ts', co-ordinated by Professor S Southon, Institute of Food Research, Norwich, UK.
Introduction
Ageing is associated with immune dysregulation, mainly affecting cell-mediated immunity and resulting in low and less adaptable immune responses compared with those of young adults (Lesourd, 1997) . In particular, with ageing, signi®cant changes occur in the pattern of lymphoid subsets, with increased numbers of immature T lymphocytes (CD2
CD3
7 ) and natural killer (NK) cells (Makinodan et al, 1987; Lesourd, 1997) . The age-related decline in cellmediated immunity is clinically signi®cant. Elderly people with low delayed-type hypersensitivity (DTH) skin test responses were less self suf®cient and had a higher incidence of morbidity, postoperative complications and mortality compared to those with normal DTH responses (Wayne et al, 1990) . Measures that can restore cell-mediated immune responsivenesss in the elderly to that seen in healthy younger individuals are potentially desirable.
Data from studies of immunocompromised or nutritionally compromised groups supports a role for an enhanced immune response following supplementation with dietary antioxidants, including ascorbic acid, vitamin E and bcarotene (Jacob et al, 1991; Prabhala et al, 1991; Garewal et al, 1992; van Poppel et al, 1993) . Several studies have shown that the immune response of healthy elderly volunteers is also enhanced by supplements containing dietary antioxidants (Meydani et al, 1990; Chandra, 1992; Santos et al, 1996) .
It has been proposed that the oxidant ± antioxidant balance is an important determinant of immune response, since cells of the immune system have a high percentage of polyunsaturated fatty acid (PUFA) in their plasma membranes and are frequently exposed to a higher number of reactive oxygen species (ROS) produced as part of their normal function (Bendich, 1991; Meydani et al, 1995) . Therefore, the mechanisms for immunoenhancement by antioxidants may include protection of the integrity of immune cell membranes. In addition, membrane-related signalling and gene expression, processes critical to the maintenance of normal immune cell function, are sensitive to oxidant stress. Exposure of human T cells to a weak oxidative stress resulted in signi®cant changes in transmembrane signal transduction and suppression of IL-2 production while treatment with the antioxidant N-acetylcysteine signi®cantly reversed these changes (Flescher et al, 1994) .
Cell-mediated immune responses involve interaction between T-helper cells and antigen presenting cells and this is mediated by expression of major histocompatability complex (MHC) class II molecules (ie HLA-DR, DP and DQ) on the cell surface of antigen presenting cells (Bach, 1985) . Other molecules including cytokines and the cell surface adhesion molecules, intercellular adhesion molecule-1 (ICAM-1) and leukocyte-function-associated antigen-3 (LFA-3) also interact during antigen presentation to T cells. Immune responsiveness has been shown to be proportional to both the percentage of MHC class II positive monocytes and also to the density of these molecules on the cell surface (Janeway et al, 1984) . Therefore, measures that can increase the expression of these molecules may enhance the immune response. In vitro studies indicate that b-carotene may modulate the expression HLA-DR (Rhodes, 1985; Gruner et al, 1986) , but varying effects of b-carotene in human supplementation studies on HLA-DR expression have been reported (Ringer et al, 1991) .
Data from several other human studies regarding the effects of b-carotene supplementation on other indices of immune response have also yielded inconsistent results. Some studies have reported stimulation of indices of the immune response (Alexander et al, 1985; Watson et al, 1991) , while more have reported no effect in healthy (Ringer et al, 1991; Daudu et al, 1994) , or immunocompromised subjects (Silverman et al, 1994) . The conversion of b-carotene to vitamin A and retinoids, which are known to have immunostimulatory effects, is one mechanism by which b-carotene may be immunostimulatory (Le Jeune et al, 1996) . However the observation that b-carotene has immunoenhancing effects independent of its conversion to vitamin A has stimulated interest in the possible immunoenhancing effects of other carotenoids (Bendich, 1991) . Lycopene, a carotenoid lacking provitamin A activity, is a potent antioxidant and oxygen quencher, and prolongs survival in mice following bacterial infection (Bendich, 1991) . Lycopene is also a major dietary and plasma carotenoid, with concentrations in the diet and in plasma second only to b-carotene in a UK population (Scott et al, 1996) , while in the US, lycopene is the predominant carotenoid, exceeding b-carotene in diet and plasma (Forman et al, 1993; Yong et al, 1994) . The present study was carried out with the aim of clarifying whether supplementation with the carotenoids, lycopene and bcarotene could enhance the immune function of healthy elderly living independently in the community.
Methods

Subjects
Healthy elderly free-living volunteers were recruited from the community using a variety of approaches, including local radio advertising, senior citizen's associations, church groups and trade unions. Fifty-eight volunteers ! 65 y were recruited following screening by medical history, physical examination and biochemical and haematological pro®le. Exclusion criteria included smoking, serum retinol less than 1 mmolal, those on special diets, taking nutritional supplements or medications known to affect immune function or absorption of nutrients, excessive alcohol consumption, underweight or obesity, 10% weight loss over the preceding 6 months, diabetes, arthritis, dementia, gastrointestinal disorders, anaemia, uncontrolled hypertension or hyperlipidaemia. Approval for this study was obtained from the Clinical Research Ethics Committee at University College Cork, Ireland, and informed consent was given by all volunteers.
The mean ( AE s.d.) age of the volunteers was 71 AE 5 y and ranged from 65 to 83 y. At screening, plasma fasting total cholesterol, total HDL cholesterol and triacylglycerols were 5.5 AE 0.9, 1.2 AE 0.3 and 1.2 AE 0.5 mmolal, respectively.
Study design
In this placebo controlled double-blind study, subjects were randomized into placebo, b-carotene and lycopene treatment groups, each receiving one capsule daily for 12 weeks. Capsules for studies carried out as part of this multi-centre project were especially produced by RP Scherer, Florida, USA. Placebo capsules provided 0.5 g corn oil, 0.06 mg a-tocopherol and 0.23 mg g-tocopherol.
Lycopene capsules, with Lyc-O-Pen TM (LycoRed Natural Products Industries Ltd, Israel) as the lycopene source, provided 13.3 mg total lycopene with 11.35 mg as alltrans-lycopene isomer, 3.5 mg a-tocopherol and 2.5 mg g-tocopherol in corn oil excipient. b-Carotene capsules, with palm fruit (Biocon Caroteen, Quest International, The Netherlands) as the source of b-carotene provided 8.2 mg Fasting blood samples were obtained at baseline and following 12 weeks supplementation. Blood samples were collected into evacuated tubes containing lithium heparin for analysis by¯ow cytometry and for analysis of lymphocyte proliferation and IL-2 production. Blood samples were collected into evacuated tubes containing 0.34 M EDTA K 3 for estimation of routine and differential haematology pro®les, plasma total fatty acids, plasma carotenoids, tocopherol and retinol and plasma total cholesterol. Samples were protected from natural light. Plasma was immediately separated and stored at 770 C until analysed.
Analysis of plasma samples
Plasma carotenoids, tocopherols and retinol were assayed by high-performance liquid chromatography as previously described in detail (Hughes et al, 1997; Hart & Scott, 1995) . Appropriate quality control standards were used in each assay.
Plasma total lipids fatty acid composition
Plasma total lipids were prepared for analysis by a one-step extraction and direct transesteri®cation method (Le Page & Roy, 1986) . Fatty acid methyl esters were analysed with a Shimatzu CG-14A gas chromatograph (Roche & Gibney, 1994) . Data was processed and expressed as %wav using Millennium version 2.1 software (Waters Corporation, Milford, USA).
Lymphocyte sub-sets by¯ow cytometry
Routine and differential haematology pro®les were performed at a local hospital (University College Hospital, Cork, Ireland). Whole blood collected in lithium heparin was incubated with: markers for total T cells (CD2 / CD19 7 ) and total B cells (CD2 7 aCD19 ) (Serotec DC 001); markers for T-helper (CD3 aCD4
) and T-suppressor (CD3 aCD8 ) cells (Dako TC 641); and markers for NK (CD3 7 aCD16
) cells (Serotec MCA 787PE and MCA 463F). Following the appropriate incubation periods, red blood cells were lysed with Immunoprep (Coulter) and cells were analysed by¯ow cytometry using a Coulter EPICS ELITE¯ow cytometer.
Expression of monocyte adhesion molecules and MHC class II molecules
Median¯uorescence intensity of expression of MHC class II molecules (DR DP DQ) expression (Serotec MCA 477PE), ICAM-1 (CD54 ; Serotec MCA 675F) and LFA-3 (CD58 ; Serotec MCA 912F) was assessed by incubating whole blood with the appropriate markers and lysing red blood cells. The monocyte population was gated and the median¯uorescence intensity calculated using the WIN MDI software program (Coulter).
Lymphocyte proliferation and cytokine production
Peripheral blood mononuclear cells were isolated from 20 ml blood collected in lithium heparin by diluting with 10 ml DMEM containing pyruvate, L-glutamine, 4500 mgal D-glucose (Gibco BRL ± Life Technologies, Paisley, UK) and with additional 100 000 IU penicillinal and 0.1 g streptomycinal (Gibco BRL), in sterile universal containers and overlaying with 20 ml Lymphoprep (Nycomed-Amersham, Oslo, Norway) in 50 ml centrifuge tubes. Tubes were centrifuged at 700 g for 30 min at room temperature. Cells at the plasmaaLymphoprep interface were removed and washed twice by centrifugation with DMEM. Cells were counted using a haemocytometer and cell viability was assessed by Trypan Blue exclusion. Cells were diluted to 1 Â 10 7 cellsaml in complete medium (10% heat inactivated foetal calf serum (Gibco BRL) in DMEM) and suspended at appropriate concentrations for measurement of mitoge-stimulated lymphocyte proliferation and induction of cytokine secretion.
Lymphocyte proliferation was measured by incorporation of 3 H-thymidine following stimulation with PHA (Sigma ± Aldrich, Poole, UK). Cells were diluted with complete medium to 1 Â 10 6 cellsaml and in stimulated wells, a ®nal PHA concentration of 2.7 mgaml and incubated in triplicate in 96-well microtitre plates. Cells were incubated at 37 C, in a humidi®ed atmosphere containing 5% CO 2 in air for 48 h. Following the addition of 3 Hthymidine for an additional 24 h, the cells were harvested and 3 H-thymidine incorporation was measured in a liquid scintillation counter (Model LS 7000, Beckman, UK). Results were reported as the average counts per min of triplicate PHA stimulated cultures minus the average counts per min of cultures without mitogen.
Cells were incubated in 6 ml polypropylene sterile culture tubes (Becton-Dickinson, Oxford, UK) at a concentration of 1 Â 10 6 cellsaml and a ®nal PHA concentration 2.7mgaml in stimulated cultures, at 37 C, in a humidi®ed atmosphere containing 5% CO 2 in air for 48 h. Culture tubes were centrifuged at 200 g for 10 min and the supernatants harvested and stored at 770 C until analysed for IL-2 and IL-4 production by solid-phase sandwich enzyme linked immuno-sorbent assay (Cytoscreen, Biosource International, USA).
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Statistical methods
Following screening, 58 eligible volunteers were recruited and 52 were included in the statistical analysis. Three volunteers did not complete the study, two were excluded for poor compliance or commencing supplementation with other nutrients and one was excluded from the analysis due to loss of sample during laboratory handling.
Analysis of covariance was used to test for differences between the treatment groups at the end of the treatment period with post-treatment as the dependent variable, treatment group as the ®xed factor and the pre-treatment assigned as covariate. The ®rst step in this general linear models analysis included treatment group and pre-treatment as main effects and included a two-way, treatment group Â pre-treatment interaction term. Following this step, analysis of covariance was repeated without the interaction term if the interaction was not signi®cant at the 1% level. If the treatment group effect was signi®cant at the 1% level when the interaction term was omitted, post-hoc Bonferroni tests with adjustment for multiple comparisons were performed on post-treatment variables. If the interaction term was signi®cant, a plot of pre-treatment against post-treatment variables was examined for trends in the data. Statistical analysis was performed with Datadesk 4.2 (Data Description Inc., New York, USA) and SPSS (SPSS Inc., Chicago, USA) statistical software packages.
Results
Subject characteristics at screening are shown in Table 1 . Subjects in all groups had normal biochemistry and haematology values (data not shown).
The effect of supplementation on plasma concentrations of carotenoids, tocopherols and retinol are shown in Table 2 . Plasma lycopene increased by 173% in the lycopene supplementation group (P 0.001). Both plasma Supplementation with lycopene or b-carotene BM Corridan et al a-carotene and plasma b-carotene increased by 494% and 247%, respectively, in the group supplemented with bcarotene (P 0.001). a-Tocopherol increased in response to supplementation in both the lycopene and b-carotene groups (P 0.043).
Lymphocyte sub-sets by¯ow cytometry
The effect of carotenoid supplementation on white blood cell (WBC) numbers and lymphocyte subpopulations is shown in Table 3 . There were no signi®cant changes in WBC, lymphocyte and monocyte counts throughout the study as assessed by routine total and differential counts. There were no signi®cant changes in the percentage or total number of cells expressing markers for total T cells or total B cells ( 
Expression of monocyte adhesion molecules and MHC class II molecules
There were no signi®cant differences in the median¯uor-escence intensity of expression of MHC class II molecules or the adhesion molecules ICAM-1 or LFA-3 on monocytes following the dietary periods (Table 5) . 
Lymphocyte proliferation and cytokine production
Lymphocyte proliferation, in unstimulated cells, or PHA stimulated cells was not signi®cantly affected by any of the treatments (Table 6 ). Lymphocyte proliferation was also expressed as counts in stimulated cells minus counts in unstimulated cells, or as a ratio of stimulated:unstimulated cells. Although lymphocyte proliferation tended to increase in all groups following supplementation, no statistically signi®cant effects were observed (data not shown). In addition, no signi®cant differences following treatment were seen in the production of the cytokines IL-2 and IL-4 in response to stimulation of peripheral blood mononuclear cells with PHA (Table 6 ).
Plasma fatty acids pro®le
Overall, treatment had no effect on plasma total lipid fatty acid composition, expressed either as a percentage of fatty acids (Table 7) , or expressed in absolute amounts (data not shown). The ratio of n-6:n-3 PUFA differed between groups, but this effect was determined by baseline values (P 0.045, treatment group Â baseline n-3 PUFA:n-6 PUFA (mmolal)). Examination of the data revealed an extreme value in the b-carotene group, with a high ratio of n-6:n-3 PUFA at baseline and after 12 weeks of treatment. Examination of the data, omitting these data points also indicated that the difference between groups was dependent on baseline ratios of n-6:n-3 PUFA (P 0.049, treatment group Â baseline n-3 PUFA:n-6 PUFA (mmolal)).
Discussion
Several previous studies have reported con¯icting ®ndings on the effect of high-dose supplementation with b-carotene (b 25 mgaday) on immune function in the elderly Daudu et al, 1994; Silverman et al, 1994) . However, the results of several prospective studies, using these levels of supplementation, have failed to show a protective effect of b-carotene in cancer prevention, in fact some have shown a detrimental effect (reviewed by Hughes, 1999) . Since these levels are above the intakes associated with a bene®cial effect of carotenoid consumption, as seen in epidemiological studies, it is possible that, as with many other nutrients, excessive intakes are potentially harmful. Therefore, this study was conducted to evaluate the effects of dietary-achievable intakes of b-carotene and lycopene on the immune status of healthy elderly men and women. Our results show no changes in the concentration or percentage of circulating white blood cells, lymphocytes or their subsets. Treatment with these carotenoids did not have any effect on the intensity of expression of MHC class II or of the adhesion molecules, LFA-3 and ICAM-1, on monocytes. Effects on lymphocyte proliferation or production of the cytokines, IL-2 and IL-4 were not discernible either, following treatment with these carotenoids. These results indicate that in this healthy elderly population, moderate supplementation with carotenoids has no bene®cial or adverse effects on immune status. It is unlikely that an inadequate tissue response to supplementation was responsible for the lack of effect on immune function. In the b-carotene supplementation group, plasma b-carotene levels were increased in response to supplementation, as were a-carotene and a-tocopherol levels. In the lycopene supplementation group, plasma lycopene levels were raised, and plasma a-tocopherol levels also increased. The increases in plasma a-carotene and a-tocopherol levels are attributable to the presence of these compounds in the supplements. Although levels of carotenoids were not measured in the peripheral blood mononuclear cells isolated in the present study, it is likely that intracellular levels in circulating cells re¯ects those present in the plasma. Long-term supplementation with 50 mg b-carotene on alternate days, resulted in four times higher levels in the PBMCs of the b-carotene groups compared to the placebo . A shorter, 44 week study, providing 60 mg b-carotene per day, resulted in a two-fold increase in mononuclear cell levels of b-carotene within 4 weeks (Murata et al, 1994) and a 1 month supplementation trial with 800 mg dl-a-tocopherol acetate resulted in a three-fold increase in a-tocopherol in PBMCs (Meydani et al, 1990) .
Plasma total lipid fatty acid composition was measured in the present study, because changes in the amount or quality of dietary fat can result in modi®cation of immune function (Meydani et al, 1993) . For instance, stimulated and unstimulated NK cell activity has been shown to correlate negatively with the concentration of total PUFA, n-6 PUFA and linoleic acid in plasma in elderly men 3.9 AE 1.0 3.7AE 0.8 3.9AE 1.3 4.1 AE 2.0 3.4 AE 1.2 3.5AE 1.0 n-6:n-3 PUFA (%) 10.8AE 3.5 11.1AE 2.6 11.0AE 2.9 10.9AE 3.4 12.5AE 4.8 12.0AE 3.5 a MeanAE s.d.
Supplementation with lycopene or b-carotene BM Corridan et al (Rasmussen et al, 1994) . However, no signi®cant changes in plasma fatty acid pro®les were observed in the present study following treatment with carotenoids. Some studies have reported changes in lymphocyte subsets in response to supplementation with b-carotene in both healthy and diseased groups. A single-blind placebo controlled study reported an increase in the ratio of CD4 :CD8 cells following 9 months of supplementation with 60 mg b-carotene daily in healthy male non-smokers aged 20 ± 25 y (Murata et al, 1994 ) and a study of healthy men and women aged 50 ± 65 y reported an increase in the percentage CD4 cells and NK cells in groups receiving b 30 mg b-carotene daily for 2 months . An increase in the percentage NK cells was reported in a non-controlled trial of men aged 35 ± 79 with either oral leukoplakia or Barrets oesophagus, who were supplemented with 30 mg b-carotene daily for 3 months . In contrast, several controlled studies in healthy young or elderly volunteers have reported no effect of supplementation with b-carotene (Ringer et al, 1991; van Poppel et al, 1993; Daudu et al, 1994; Santos et al, 1996) , or indeed vitamin E (Meydani et al, 1995) , on lymphocyte subsets. The results from the studies of disease groups should be interpreted with care, bearing in mind the dif®culty in controlling these trials adequately. This may account for the increase in the percentage NK cells at 3 months, but not at 4 months in an uncontrolled b-carotene supplementation trial of HIV patients (Garewal et al, 1992) . The controlled studies in healthy volunteers that do report a positive effect of b-carotene on lymphocyte subsets, also contain some anomalous ®ndings. Murata et al (1994) reported an increase in the ratio of CD4:CD8 cells only at 9 months, but not at 3 months and observed no other signi®cant changes in the percentage of CD4 , CD8
, B cells, total T cells, NK cells or other lymphocyte subsets. Watson et al (1991) only observed effects on lymphocyte subsets at higher doses, and interpretation of this dose ± response study is impeded by including only four volunteers at each level of supplementation. Santos et al (1997) have recently reported the results of two studies in the elderly; a short-term, high-dose study (90 mgaday for 21 days) in women and a longer-term, lower-dose trial (50 mgaalternate days for 10 ± 12 y) in men. Both studies concluded that there was no signi®cant difference in T cell function as assessed by DTH response, lymphocyte proliferation, IL-2 and prostaglandin E2 production, and composition of lymphocyte subsets. Further support for the lack of effect of carotenoids on lymphocyte subsets observed in the present study is provided by a depletion ± repletion study in which plasma carotenoids were reduced by 63% or increased by 660% without having any effect on lymphocyte subsets (Daudu et al, 1994) .
Examination of the expression of several cell surface molecules involved in antigen presentation and cell activation also failed to show any signi®cant effect of carotenoid supplementation in the present study. Another study, providing b-carotene at doses ranging from 15 to 300 mg daily for 1 month observed no signi®cant effect on lymphocyte expression of HLA-DR (Ringer et al, 1991) . However, Hughes et al (1997) reported that supplementation with 15 mg b-carotene daily for 26 days resulted in a signi®cant increase in the percentage of monocytes expressing HLA-DR, ICAM-1 and LFA-3, in a group of middle-aged males. Possible explanations for the differences in the results of these studies include differences in the dose of b-carotene administered, and differences in analysis. The results of the earlier study (Hughes et al, 1997) suggested that there is a dose dependent effect of b-carotene on surface molecule expression, since after a 4 week washout period postsupplementation, when plasma levels of b-carotene had fallen, but not back to baseline, expression of HLA-DR remained signi®cantly elevated, whilst expression of ICAM-1 and LFA-3 had returned to baseline levels, suggesting that different plasma concentrations of b-carotene are required to enhance the expression of different surface molecules. In addition, in the earlier study monocytes were puri®ed prior to immuno¯uorescent staining and the MHC class II molecules HLA-DR, -DP and -DQ were examined separately (these workers observed no changes in HLA-DP or -DQ expression). Therefore, more subtle changes in monocyte surface molecule expression might have been detected compared with the current study where whole blood samples were stained with combined antibodies, or where lymphocytes were examined, which express much lower numbers of HLA-DR molecules than do monocytes. Hughes and colleagues have also reported that lycopene, at a dose of 15 mgaday did not have as signi®cant an effect on monocyte surface molecule expression as had b-carotene at the same dose (Hughes et al, 2000) . In vitro studies indicate that b-carotene and canthaxanthin together reduced the inhibition of macrophage HLA-DR antigen following exposure to reactive oxygen intermediates (Gruner et al, 1986) . Further studies are required to examine both possible dose ± response effects and synergistic effects of combined carotenoid supplements.
In the present study, supplementation with b-carotene or lycopene did not signi®cantly alter the in vitro proliferation of peripheral blood mononuclear cells cultured with PHA. This contrasts with the increased lymphocyte proliferation observed in animals fed nutritionally complete diets and supplemented with either b-carotene or canthaxanthin (Bendich, 1991) . However, the dose of carotenoids used in this animal study was considerably higher than that consumed by humans on Western diets. In human studies, van Poppel et al (1993) reported an increase in lymphocyte proliferation in PHA-stimulated cultures but not in Con A-stimulated cultures following dietary supplementation with 20 mg b-carotene daily for 14 weeks. b-Carotene, or vitamin C, depletion ± repletion studies have failed to show an effect on lymphocyte proliferation in response in healthy volunteers (Jacob et al, 1991; Daudu et al, 1994) and immunocompromised groups also fail to show consistent improvements in lymphocyte proliferation in response to supplementation (Garewal et al, 1992; Zhang et al, 1995) .
Supplementation with lycopene or b-carotene BM Corridan et al There have been two recent studies examining the effects of lycopene on human immune function. In the ®rst, male volunteers were provided with a carotenoid-de®cient diet for 2 weeks, followed by 2 weeks of dietary-enrichment with lycopene (40 mgaday present in tomato juice). After the low-carotenoid period there was a signi®cant decrease in T cell proliferation to concanavalin A (con A, a similar mitogen to PHA) compared with baseline values, but proliferative activity was restored following the lycopenerich dietary period (Watzl et al, 1999) . In the second study, the same workers gave a group of elderly volunteers (aged 63 ± 86 y) 47 mgaday lycopene (in tomato juice) for 8 weeks and found no signi®cant effect on lymphocyte proliferation (Watzl et al, 2000) . These authors also concluded that lycopene does not signi®cantly affect cell-mediated immunity in well-nourished elderly subjects.
No effect of carotenoid supplementation on IL-2 or IL-4 production in PBMCs stimulated with PHA was observed in the present study. Supplementation studies of healthy humans have reported increased production of IL-2, IL-1b and TNF-a by PBMCs in response to vitamin E (Meydani et al, 1990; Jeng et al, 1996) . However, one of these studies only observed a transient increase in cytokine production and only observed this effect in volunteers who were also supplemented with vitamin C (Jeng et al, 1996) . Human studies tend not to support an enhancement of IL-2 production in response to supplementation with b-carotene. A short-term placebo-controlled study providing doses of b-carotene in the range 15 ± 300 mgaday to healthy volunteers, observed no effect on production of IL-2 by PBMCs stimulated with PHA (Ringer et al, 1991) . Furthermore, a long-term placebo-controlled double-blind study examining the effect of 10 ± 12 y b-carotene supplementation (50 mg on alternate days) reported no signi®cant effect on IL-2 production or PGE 2 production by stimulated PBMCs, in either middle-aged or elderly men . Watzl et al (2000) also looked at cytokine secretion following dietary enrichment with lycopene in their group of elderly subjects. Although they saw an increase in IL-4 production, together with a decrease in IL-2, following dietary enrichment with lycopene, they also observed similar effects in their untreated control group. Although the reason for these ®ndings is unknown, they support the suggestion that carotenoids do not signi®cantly modulate lymphocyte cytokine secretion in well-nourished elderly subjects.
Plasma carotenoids tended to be lower in the elderly group in the present study than in a younger group of volunteers, drawn from the same population (Carroll et al, 1999) . However, the elderly volunteers in this population had nutrient intakes comparable to those reported in the group of younger volunteers (detailed in Table 5 ; Carroll et al, 1999) . Furthermore, the exclusion criteria, including the biochemical and haematological indices, de®ned for the present study, resulted in selection of healthy elderly volunteers for this study. This indicates that the volunteers in the present study were healthy and well nourished and raises the possibility that their immune response was optimal or near-optimal prior to entering the study. This may be another explanation as to why no improvement in immune function was observed in the present study. Indeed, a study examining the relationship between nutrition status and in vitro indices of immune responses found no evidence of a relationship between nutrition factors and NK cell activity in healthy, independently living elderly volunteers (Payette et al, 1990) .
In conclusion, data from the present study supports the hypothesis that low levels of dietary supplementation with carotenoids do not signi®cantly affect cell-mediated immunity in well-nourished elderly populations who already possess near-optimal immune status.
